Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 193 to 200 of 200 entries
Sorted by: Best Match Show Resources per page
Implementation of a Standardized Perioperative Pain Management Protocol to Reduce Opioid Prescriptions in Otolaryngologic Surgery.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Chang MT, Lalakea ML, Shepard K, Saste M, Munoz A, Amoils M.
PMID: 35015583
Otolaryngol Head Neck Surg. 2022 Jan 11;1945998211071116. doi: 10.1177/01945998211071116. Epub 2022 Jan 11.

OBJECTIVE: To evaluate the efficacy of implementing a standardized multimodal perioperative pain management protocol in reducing opioid prescriptions following otolaryngologic surgery.STUDY DESIGN: Retrospective cohort study.SETTING: County hospital otolaryngology practice.METHODS: A perioperative pain management protocol was implemented in adults undergoing...

Cite
Chang MT, Lalakea ML, Shepard K, et al. Implementation of a Standardized Perioperative Pain Management Protocol to Reduce Opioid Prescriptions in Otolaryngologic Surgery. Otolaryngol Head Neck Surg. 2022;1945998211071116doi: 10.1177/01945998211071116.
Chang, M. T., Lalakea, M. L., Shepard, K., Saste, M., Munoz, A., & Amoils, M. (2022). Implementation of a Standardized Perioperative Pain Management Protocol to Reduce Opioid Prescriptions in Otolaryngologic Surgery. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1945998211071116. https://doi.org/10.1177/01945998211071116
Chang, Michael T, et al. "Implementation of a Standardized Perioperative Pain Management Protocol to Reduce Opioid Prescriptions in Otolaryngologic Surgery." Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery vol. (2022): 1945998211071116. doi: https://doi.org/10.1177/01945998211071116
Chang MT, Lalakea ML, Shepard K, Saste M, Munoz A, Amoils M. Implementation of a Standardized Perioperative Pain Management Protocol to Reduce Opioid Prescriptions in Otolaryngologic Surgery. Otolaryngol Head Neck Surg. 2022 Jan 11;1945998211071116. doi: 10.1177/01945998211071116. Epub 2022 Jan 11. PMID: 35015583.
Copy Download .nbib Format: NLM
Does anesthetic relief correspond to future pain relief? A prospective trial examining future pain relief for ultrasound-guided corticosteroid-anesthetic injections.

American journal of physical medicine & rehabilitation

Cushman DM, Knox J, Kobayashi JK, Zarate M, Wheelwright JC, Monson N, English J, Teramoto M.
PMID: 35019871
Am J Phys Med Rehabil. 2022 Jan 10; doi: 10.1097/PHM.0000000000001959. Epub 2022 Jan 10.

OBJECTIVE: To prospectively evaluate the association between immediate pain relief from injections of local anesthetic with corticosteroid and subsequent pain relief up to three months. The secondary aim was to examine the time until subjective pain relief following these...

Cite
Cushman DM, Knox J, Kobayashi JK, et al. Does anesthetic relief correspond to future pain relief? A prospective trial examining future pain relief for ultrasound-guided corticosteroid-anesthetic injections. Am J Phys Med Rehabil. 2022;doi: 10.1097/PHM.0000000000001959.
Cushman, D. M., Knox, J., Kobayashi, J. K., Zarate, M., Wheelwright, J. C., Monson, N., English, J., & Teramoto, M. (2022). Does anesthetic relief correspond to future pain relief? A prospective trial examining future pain relief for ultrasound-guided corticosteroid-anesthetic injections. American journal of physical medicine & rehabilitation, . https://doi.org/10.1097/PHM.0000000000001959
Cushman, Daniel M, et al. "Does anesthetic relief correspond to future pain relief? A prospective trial examining future pain relief for ultrasound-guided corticosteroid-anesthetic injections." American journal of physical medicine & rehabilitation vol. (2022). doi: https://doi.org/10.1097/PHM.0000000000001959
Cushman DM, Knox J, Kobayashi JK, Zarate M, Wheelwright JC, Monson N, English J, Teramoto M. Does anesthetic relief correspond to future pain relief? A prospective trial examining future pain relief for ultrasound-guided corticosteroid-anesthetic injections. Am J Phys Med Rehabil. 2022 Jan 10; doi: 10.1097/PHM.0000000000001959. Epub 2022 Jan 10. PMID: 35019871.
Copy Download .nbib Format: NLM
Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome.

Case reports in medicine

Arasteh M, Shami S, Nasseri K.
PMID: 22548079
Case Rep Med. 2012;2012:585713. doi: 10.1155/2012/585713. Epub 2012 Apr 03.

Electroconvulsive therapy can be effective in severe or treatment resistant neuroleptic malignant syndrome patients. Anesthesia and use of muscle relaxant agents for electroconvulsive therapy in such patients may encounter anesthesiologists with specific challenges. This case report describes successful management...

Cite
Arasteh M, Shami S, Nasseri K. Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome. Case Rep Med. 2012;2012:585713doi: 10.1155/2012/585713.
Arasteh, M., Shami, S., & Nasseri, K. (2012). Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome. Case reports in medicine, 2012585713. https://doi.org/10.1155/2012/585713
Arasteh, Modabber, et al. "Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome." Case reports in medicine vol. 2012 (2012): 585713. doi: https://doi.org/10.1155/2012/585713
Arasteh M, Shami S, Nasseri K. Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome. Case Rep Med. 2012;2012:585713. doi: 10.1155/2012/585713. Epub 2012 Apr 03. PMID: 22548079; PMCID: PMC3324269.
Copy Download .nbib Format: NLM
Resection of tuber centers only for seizure control in tuberous sclerosis complex.

Epilepsy research

Stephenson SEM, Maixner WJ, Barton SM, D'Arcy C, Mandelstam SA, MacGregor D, Lockhart PJ, Leventer RJ, Harvey AS.
PMID: 33662678
Epilepsy Res. 2021 Mar;171:106572. doi: 10.1016/j.eplepsyres.2021.106572. Epub 2021 Feb 08.

Our previous studies suggest the tuber center is the seizure focus in tuberous sclerosis complex (TSC). We report findings from 5 epilepsy surgeries in 4 children with TSC and focal motor seizures from single tubers in primary sensorimotor cortex...

Cite
Stephenson SEM, Maixner WJ, Barton SM, et al. Resection of tuber centers only for seizure control in tuberous sclerosis complex. Epilepsy Res. 2021;171:106572doi: 10.1016/j.eplepsyres.2021.106572.
Stephenson, S. E. M., Maixner, W. J., Barton, S. M., D'Arcy, C., Mandelstam, S. A., MacGregor, D., Lockhart, P. J., Leventer, R. J., & Harvey, A. S. (2021). Resection of tuber centers only for seizure control in tuberous sclerosis complex. Epilepsy research, 171106572. https://doi.org/10.1016/j.eplepsyres.2021.106572
Stephenson, Sarah E M, et al. "Resection of tuber centers only for seizure control in tuberous sclerosis complex." Epilepsy research vol. 171 (2021): 106572. doi: https://doi.org/10.1016/j.eplepsyres.2021.106572
Stephenson SEM, Maixner WJ, Barton SM, D'Arcy C, Mandelstam SA, MacGregor D, Lockhart PJ, Leventer RJ, Harvey AS. Resection of tuber centers only for seizure control in tuberous sclerosis complex. Epilepsy Res. 2021 Mar;171:106572. doi: 10.1016/j.eplepsyres.2021.106572. Epub 2021 Feb 08. PMID: 33662678.
Copy Download .nbib Format: NLM
Annexin A2 binds the internal ribosomal entry site of c-.

RNA biology

Strand E, Hollås H, Sakya SA, Romanyuk S, Saraste MEV, Grindheim AK, Patil SS, Vedeler A.
PMID: 34346292
RNA Biol. 2021 Oct 15;18:337-354. doi: 10.1080/15476286.2021.1947648. Epub 2021 Aug 04.

The expression and localization of the oncoprotein c-Myc is highly regulated at the level of transcription, mRNA transport, translation, as well as stability of the protein. We previously showed that Annexin A2 (AnxA2) binds to a specific localization element...

Cite
Strand E, Hollås H, Sakya SA, et al. Annexin A2 binds the internal ribosomal entry site of c-. RNA Biol. 2021;18:337-354doi: 10.1080/15476286.2021.1947648.
Strand, E., Hollås, H., Sakya, S. A., Romanyuk, S., Saraste, M. E. V., Grindheim, A. K., Patil, S. S., & Vedeler, A. (2021). Annexin A2 binds the internal ribosomal entry site of c-. RNA biology, 18337-354. https://doi.org/10.1080/15476286.2021.1947648
Strand, Elin, et al. "Annexin A2 binds the internal ribosomal entry site of c-." RNA biology vol. 18 (2021): 337-354. doi: https://doi.org/10.1080/15476286.2021.1947648
Strand E, Hollås H, Sakya SA, Romanyuk S, Saraste MEV, Grindheim AK, Patil SS, Vedeler A. Annexin A2 binds the internal ribosomal entry site of c-. RNA Biol. 2021 Oct 15;18:337-354. doi: 10.1080/15476286.2021.1947648. Epub 2021 Aug 04. PMID: 34346292.
Copy Download .nbib Format: NLM
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.

European heart journal

Banning AP, Serruys P, De Maria GL, Ryan N, Walsh S, Gonzalo N, Jan van Geuns R, Onuma Y, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, Piek JJ, Appleby C, Fath-Ordoubadi F, Zaman A, Van Mieghem NM, Uren N, Zueco J, Buszman P, Iniguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, de Vries T, Taggart D, Farooq V, Spitzer E, Tijssen J, Escaned J.
PMID: 34617993
Eur Heart J. 2021 Oct 07; doi: 10.1093/eurheartj/ehab703. Epub 2021 Oct 07.

AIMS: The SYNTAX II study evaluated the impact of advances in percutaneous coronary intervention (PCI), integrated into a single revascularization strategy, on outcomes of patients with de novo three-vessel disease. The study employed decision-making utilizing the SYNTAX score II,...

Cite
Banning AP, Serruys P, De Maria GL, et al. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab703.
Banning, A. P., Serruys, P., De Maria, G. L., Ryan, N., Walsh, S., Gonzalo, N., Jan van Geuns, R., Onuma, Y., Sabate, M., Davies, J., Lesiak, M., Moreno, R., Cruz-Gonzalez, I., Hoole, S. P., Piek, J. J., Appleby, C., Fath-Ordoubadi, F., Zaman, A., Van Mieghem, N. M., Uren, N., Zueco, J., Buszman, P., Iniguez, A., Goicolea, J., Hildick-Smith, D., Ochala, A., Dudek, D., de Vries, T., Taggart, D., Farooq, V., Spitzer, E., Tijssen, J., & Escaned, J. (2021). Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. European heart journal, . https://doi.org/10.1093/eurheartj/ehab703
Banning, Adrian P, et al. "Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab703
Banning AP, Serruys P, De Maria GL, Ryan N, Walsh S, Gonzalo N, Jan van Geuns R, Onuma Y, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, Piek JJ, Appleby C, Fath-Ordoubadi F, Zaman A, Van Mieghem NM, Uren N, Zueco J, Buszman P, Iniguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, de Vries T, Taggart D, Farooq V, Spitzer E, Tijssen J, Escaned J. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. Eur Heart J. 2021 Oct 07; doi: 10.1093/eurheartj/ehab703. Epub 2021 Oct 07. PMID: 34617993.
Copy Download .nbib Format: NLM
Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit.

Frontiers in medicine

Suarez-Cuartin G, Gasa M, Bermudo G, Ruiz Y, Hernandez-Argudo M, Marin A, Trias-Sabria P, Cordoba A, Cuevas E, Sarasate M, Ariza A, Sabater J, Romero N, Subirana C, Molina-Molina M, Santos S.
PMID: 34277674
Front Med (Lausanne). 2021 Jul 01;8:711027. doi: 10.3389/fmed.2021.711027. eCollection 2021.

No abstract available.

Cite
Suarez-Cuartin G, Gasa M, Bermudo G, et al. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Front Med (Lausanne). 2021;8:711027doi: 10.3389/fmed.2021.711027.
Suarez-Cuartin, G., Gasa, M., Bermudo, G., Ruiz, Y., Hernandez-Argudo, M., Marin, A., Trias-Sabria, P., Cordoba, A., Cuevas, E., Sarasate, M., Ariza, A., Sabater, J., Romero, N., Subirana, C., Molina-Molina, M., & Santos, S. (2021). Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Frontiers in medicine, 8711027. https://doi.org/10.3389/fmed.2021.711027
Suarez-Cuartin, Guillermo, et al. "Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit." Frontiers in medicine vol. 8 (2021): 711027. doi: https://doi.org/10.3389/fmed.2021.711027
Suarez-Cuartin G, Gasa M, Bermudo G, Ruiz Y, Hernandez-Argudo M, Marin A, Trias-Sabria P, Cordoba A, Cuevas E, Sarasate M, Ariza A, Sabater J, Romero N, Subirana C, Molina-Molina M, Santos S. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Front Med (Lausanne). 2021 Jul 01;8:711027. doi: 10.3389/fmed.2021.711027. eCollection 2021. PMID: 34277674; PMCID: PMC8280318.
Copy Download .nbib Format: NLM
Abrasion and Erosion Resistance of Cermets: A Review.

Materials (Basel, Switzerland)

Kübarsepp J, Juhani K, Tarraste M.
PMID: 35009216
Materials (Basel). 2021 Dec 22;15(1). doi: 10.3390/ma15010069.

WC-based hardmetals are employed widely as wear-resistant ceramic-metal composites for tools and wear parts. Raw materials supply, environmental concerns and some limitations of hardmetals have directed efforts toward development of alternative wear-resistant composites-cermets. We present a current state of...

Cite
Kübarsepp J, Juhani K, Tarraste M. Abrasion and Erosion Resistance of Cermets: A Review. Materials (Basel). 2021;15(1)doi: 10.3390/ma15010069.
Kübarsepp, J., Juhani, K., & Tarraste, M. (2021). Abrasion and Erosion Resistance of Cermets: A Review. Materials (Basel, Switzerland), 15(1), . https://doi.org/10.3390/ma15010069
Kübarsepp, Jakob, et al. "Abrasion and Erosion Resistance of Cermets: A Review." Materials (Basel, Switzerland) vol. 15,1 (2021). doi: https://doi.org/10.3390/ma15010069
Kübarsepp J, Juhani K, Tarraste M. Abrasion and Erosion Resistance of Cermets: A Review. Materials (Basel). 2021 Dec 22;15(1). doi: 10.3390/ma15010069. PMID: 35009216.
Copy Download .nbib Format: NLM
Showing 193 to 200 of 200 entries